Specifically, the GLP-1/GIP vial contains four weekly doses each of 2.5 mg, 5 mg, and 7.5 mg, while the GLP-1 vial contains four weekly doses each of 0.25 mg, 0.5 mg, and 1 mg
The Adherence Factor: Patients using remote monitoring platforms with weekly symptom checks show significantly higher medication adherence compared to standard care
Which GLP-1 was most likely and least likely to have cutaneous side effects
Digestive symptoms such as persistent diarrhea, abdominal pain, rectal bleeding, unexplained weight loss, fever, severe bloating, food intolerance patterns, or nighttime bowel movements deserve medical attention
Receiving Assistance and Ongoing Support If approved, patients will receive information on how to obtain their medication
Rosen, M.D